Alignment Healthcare, Inc. Common Stock

On Thursday, Alignment Healthcare Inc (NASDAQ:ALHC) reported a first-quarter EPS loss of $(0.25), up from $(0.20) a year ago, missing the consensus of $(0.22). The company reported sales of $628.6 million, up 43.1% Y/Y, beating the consensus of $595.13 million and the management guidance of $590 million-$600 million. The medical benefits ratio based on adjusted gross profit was 90.9%. Health plan membership at the end of the quarter was approximately 165,100, up 50.5% Y/Y. Guidance: Alignment Healthcare expects Q2 revenues of $625 million—$635 million versus the consensus of $608.65 million. The company raised its fiscal year 2024 sales outlook from $2.38 billion—$2.41 billion to $2.495 billion—$2.525 billion, compared to the ...Full story available on Benzinga.com

Related tickers: ALHC.

While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Related tickers: ALHC.